ENTITY

Beta Bionics (BBNX US)

18
Analysis
Health Care • United States
Beta Bionics, Inc. is a commercial-stage medical device company. The Company offers an automated insulin delivery system with closed-loop algorithms for the treatment of people with diabetes. Beta Bionics operates in the United States.
more
Exchange Announcement • 16 Sep 2026 04:58

Current Report (Form 8-K | Period ending 2026-09-14)

Exchange Announcement • 30 Jul 2026 04:04

Current Report (Form 8-K | Period ending 2026-07-29)

Exchange Announcement • 29 Jul 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 23 May 2026 04:05

Current Report (Form 8-K | Period ending 2026-05-21)

Exchange Announcement • 22 May 2026 04:06

Current Report (Form 8-K | Period ending 2026-05-21)

x